Skip to main content
Download PDF

Volume 9 Supplement 2

15th Scientific Symposium of the Austrian Pharmacological Society (APHAR)

Protein kinase C-ζ is involved in the inhibition of eosinophil migration

BMC Pharmacology volume 9, Article number: A34 (2009) Cite this article

Background

The accumulation of eosinophils in lung tissue is a hallmark of asthma, and it is believed that eosinophils play a crucial pathogenic role in allergic inflammation. Therefore, eosinophils are currently considered a major therapeutic target in allergic diseases. Prostaglandin (PG) E2 exerts anti-inflammatory and broncho-protective mechanisms in asthma, but the underlying mechanisms have remained unclear. We have shown previously that PGE2 and the EP2 receptor agonist butaprost inhibit eosinophil trafficking in vitro and in vivo [1].

Methods

Human eosinophils were purified by negative magnetic selection from peripheral blood. Chemotaxis was determined in 48-well microBoyden chambers and migrated eosinophils were enumerated by flow cytometry.

Results

The chemotaxis of human eosinophils towards the chemoattractant eotaxin was attenuated by PGE2 and the selective EP4 agonist ONO-AE1-329 in a concentration-dependent manner. Pretreatment of eosinophils with the adenylyl cyclase inhibitor SQ-22536, the protein kinase A inhibitor H-89 or the p38 MAP kinase inhibitor SB-202190 did not prevent the inhibitory effect of PGE2, while the phosphatidyl inositol 3-kinase (PI3K) inhibitor LY-294002, triciribine, a specific inhibitor of Akt phosphorylation, and a myristoylated pseudosubstrate of protein kinase (PK) C-ζ (mPS), partially or completely reversed the inhibitory effect of PGE2 and ONO-AE1-329 on the migration of eosinophils towards eotaxin.

Conclusion

Protein kinase C is an increasingly diverse family of enzymes that has been implicated in a range of cellular functions within the eosinophil. The present data show that the PI3K/Akt/PKC-ζ pathway is involved in the negative regulation of the migration of human eosinophils mediated by EP2 and EP4 receptor activation.

References

  1. Sturm EM, Schratl P, Schuligoi R, Konya V, Sturm GJ, Lippe IT, Peskar BA, Heinemann A: Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J Immunol. 2008, 181: 7273-7283.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010, Graz, Austria

    Eva M Sturm, Gerald P Parzmair, Petra Luschnig-Schratl, Viktória Kónya & Ákos Heinemann

Authors
  1. Eva M Sturm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald P Parzmair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petra Luschnig-Schratl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Viktória Kónya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ákos Heinemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ákos Heinemann.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Sturm, E.M., Parzmair, G.P., Luschnig-Schratl, P. et al. Protein kinase C-ζ is involved in the inhibition of eosinophil migration. BMC Pharmacol 9 (Suppl 2), A34 (2009). https://doi.org/10.1186/1471-2210-9-S2-A34

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1471-2210-9-S2-A34

Keywords

BMC Pharmacology

ISSN: 1471-2210